Delivery Order SPE2DR25D2002-SPE2DR26FBSU2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,114.96 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.12 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $3,449.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count). The contract is a non-set-aside competitive award with a completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $1,392.76 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on December 10, 2025, with a completion date of December 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.06 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on December 16, 2025, with completion due by December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,803.01 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 18, 2025, with ultimate completion scheduled for November 19, 2025. The contract utilizes firm fixed-price pricing and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,099.55 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg. The contract is classified as Firm Fixed Price with a completion date of December 18, 2025, and was awarded on December 17, 2025. This delivery order is non-set-aside and represents a competitively awarded transaction under AmerisourceBergen's larger contract vehicle with the federal government. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,306.32 for 100 capsules of dextroamphetamine-amphetamine 10 mg, with a completion deadline of December 8, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a discrete pharmaceutical procurement to support federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a contract ceiling value of $1,594.31. This firm fixed-price delivery order, which is set to be completed by December 19, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis and represents a child contract under...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBSU2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,414.29 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on December 19, 2025, with an ultimate completion date of December 22, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply chain requirements across multiple therapeutic domains, positioning the contractor as a critical vendor for federal pharmaceutical procurement supporting Defense Health Agency and U.S. Coast Guard healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/18/25 |